Alpha 2.0
Login Register
» Articles » PMID: 32588943

Obesity and Diabetes As High-risk Factors for Severe Coronavirus Disease 2019 (Covid-19)

Overview
Journal Diabetes Metab Res Rev
Specialty Endocrinology
Date 2020 Jun 27
PMID 32588943
Citations 257
Authors
Yue Zhou
Jingwei Chi
Wenshan Lv
Yangang Wang
Affiliations
Soon will be listed here.
Abstract

The outbreak of the coronavirus disease 2019 (Covid-19) has become an evolving worldwide health crisis. With the rising prevalence of obesity and diabetes has come an increasing awareness of their impacts on infectious diseases, including increased risk for various infections, post-infection complications and mortality from critical infections. Although epidemiological and clinical characteristics of Covid-19 have been constantly reported, no article has systematically illustrated the role of obesity and diabetes in Covid-19, or how Covid-19 affects obesity and diabetes, or special treatment in these at-risk populations. Here, we present a synthesis of the recent advances in our understanding of the relationships between obesity, diabetes and Covid-19 along with the underlying mechanisms, and provide special treatment guidance for these at-risk populations.

Citing Articles

Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity.

Zhang J, Wei J, Lai W, Sun J, Bai Y, Cao H Int J Mol Sci. 2025; 26(4).

PMID: 40004115 PMC: 11855704. DOI: 10.3390/ijms26041651.

Addressing childhood obesity in Iran: exploring a multifaceted conceptual model in a low/middle income country through stakeholder lens.

Toorang F, Amiri P, Pouraram H, Takian A BMC Public Health. 2025; 25(1):772.

PMID: 40001077 PMC: 11853819. DOI: 10.1186/s12889-024-21221-1.

Correlation of diabetes and adverse outcomes in hospitalized COVID-19 patients admitted to a tertiary hospital in China during a small-scale COVID-19 outbreak.

Li Y, Li G, Li J, Luo Z, Lin Y, Lan N PeerJ. 2025; 13:e18865.

PMID: 39886017 PMC: 11781264. DOI: 10.7717/peerj.18865.

COVID-19 and HIV: Clinical Outcomes and Inflammatory Markers in a Cohort from a Reference Hospital in Rio de Janeiro, Brazil.

de Sa N, Macieira K, Coelho M, Goulart M, Ribeiro-Alves M, Rosadas L Viruses. 2025; 17(1.

PMID: 39861879 PMC: 11769093. DOI: 10.3390/v17010091.

Changes in Lifestyle Behaviors, Shopping Habits and Body Weight Among Adults in Cyprus and Greece During COVID-19 Lockdown: A Cross-Sectional Study.

Andreou E, Georgaki E, Vlahoyiannis A, Philippou C, Ntorzi N, Christoforou C Nutrients. 2025; 17(2.

PMID: 39861344 PMC: 11767316. DOI: 10.3390/nu17020214.

References
1.
Hameed I, Masoodi S, Mir S, Nabi M, Ghazanfar K, Ganai B . Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J Diabetes. 2015; 6(4):598-612. PMC: 4434080. DOI: 10.4239/wjd.v6.i4.598. View
2.
Vangipuram S, Sheele J, Atkinson R, Holland T, Dhurandhar N . A human adenovirus enhances preadipocyte differentiation. Obes Res. 2004; 12(5):770-7. DOI: 10.1038/oby.2004.93. View
3.
Defuria J, Belkina A, Jagannathan-Bogdan M, Snyder-Cappione J, Carr J, Nersesova Y . B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013; 110(13):5133-8. PMC: 3612635. DOI: 10.1073/pnas.1215840110. View
4.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View
5.
Cho W, Lee D, Lee S, Sohn S, Park H, Park Y . Diet-induced obesity reduces the production of influenza vaccine-induced antibodies via impaired macrophage function. Acta Virol. 2016; 60(3):298-306. DOI: 10.4149/av_2016_03_298. View